Drug
Tisotumab Vedotin
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Conjunctivitis | 42 | 52.7 | 55.2 | signal |
| 2 | Dry Eye | 51 | 24.2 | 25.6 | signal |
| 3 | Eye Discharge | 10 | 22.5 | 22.8 | signal |
| 4 | Hospice Care | 9 | 21.0 | 21.2 | signal |
| 5 | Eye Disorder | 28 | 19.7 | 20.2 | signal |
| 6 | Neuropathy Peripheral | 74 | 18.0 | 19.5 | signal |
| 7 | Malignant Neoplasm Progression | 70 | 15.8 | 17.0 | signal |
| 8 | Ocular Discomfort | 7 | 14.8 | 14.9 | signal |
| 9 | Vaginal Haemorrhage | 20 | 10.8 | 11.0 | signal |
| 10 | Eye Inflammation | 3 | 7.3 | 7.3 | signal |
| 11 | Neoplasm Progression | 11 | 7.2 | 7.3 | signal |